메뉴 건너뛰기




Volumn 29, Issue 6, 2008, Pages 644-653

A comparison of olopatadine 0.2% ophthalmic solution versus fluticasone furoate nasal spray for the treatment of allergic conjunctivitis

Author keywords

Allergic conjunctivitis; Allergic rhinitis; Allergy; Conjunctival allergen challenge; Fluticasone furoate; Intranasal corticosteroid; Olopatadine; Pataday; Rhinoconjunctivitis; Veramyst

Indexed keywords

EYE DROPS; FLUTICASONE FUROATE; NOSE SPRAY; OLOPATADINE; PLACEBO; SODIUM CHLORIDE; ANDROSTANE DERIVATIVE; ANTIALLERGIC AGENT; DIBENZOXEPIN DERIVATIVE;

EID: 61749094990     PISSN: 10885412     EISSN: 15396304     Source Type: Journal    
DOI: 10.2500/aap.2008.29.3176     Document Type: Article
Times cited : (16)

References (36)
  • 1
    • 0006072587 scopus 로고    scopus 로고
    • Worldwide variations in prevalence of symptoms of allergic rhinoconjunctivitis in children: The International Study of Asthma and Allergies in Childhood (ISAAC)
    • Strachan D, Sibbald B, Weiland S, et al. Worldwide variations in prevalence of symptoms of allergic rhinoconjunctivitis in children: The International Study of Asthma and Allergies in Childhood (ISAAC). Pediatr Allergy Immunol 8:161-176, 1997.
    • (1997) Pediatr Allergy Immunol , vol.8 , pp. 161-176
    • Strachan, D.1    Sibbald, B.2    Weiland, S.3
  • 2
    • 0029995516 scopus 로고    scopus 로고
    • Variations in the prevalence of respiratory symptoms, self-reported asthma attacks, and the use of asthma medication in the European Community Respiratory Health Survey (ECRHS)
    • European Community Respiratory Health Survey ECRHS
    • European Community Respiratory Health Survey (ECRHS). Variations in the prevalence of respiratory symptoms, self-reported asthma attacks, and the use of asthma medication in the European Community Respiratory Health Survey (ECRHS). Eur Respir J 9:687-695, 1996.
    • (1996) Eur Respir J , vol.9 , pp. 687-695
  • 3
    • 0024417450 scopus 로고
    • Hay fever, hygiene, and household size
    • Strachan DP. Hay fever, hygiene, and household size. BMJ 299:1259-1260, 1989.
    • (1989) BMJ , vol.299 , pp. 1259-1260
    • Strachan, D.P.1
  • 4
    • 27644538902 scopus 로고    scopus 로고
    • Household hygiene practices in relation to dampness at home and current wheezing and rhino-conjunctivitis among school age children
    • Zhang G, Spickett J, Lee AH, et al. Household hygiene practices in relation to dampness at home and current wheezing and rhino-conjunctivitis among school age children. Pediatr Allergy Immunol 16:587-592, 2005.
    • (2005) Pediatr Allergy Immunol , vol.16 , pp. 587-592
    • Zhang, G.1    Spickett, J.2    Lee, A.H.3
  • 5
    • 17044404657 scopus 로고    scopus 로고
    • Changing prevalence of asthma in Taiwanese adolescents: Two surveys 6 years apart
    • Lee Y, Lin Y, Hwang B, and Guo Y. Changing prevalence of asthma in Taiwanese adolescents: Two surveys 6 years apart. Pediatr Allergy Immunol 16:157-164, 2005.
    • (2005) Pediatr Allergy Immunol , vol.16 , pp. 157-164
    • Lee, Y.1    Lin, Y.2    Hwang, B.3    Guo, Y.4
  • 6
    • 0034757928 scopus 로고    scopus 로고
    • Air pollutants enhance rhinoconjunctivitis symptoms in pollen-allergic individuals
    • Riediker M, Monn C, Koller T, et al. Air pollutants enhance rhinoconjunctivitis symptoms in pollen-allergic individuals. Ann Allergy Asthma Immunol 87:311-318, 2001.
    • (2001) Ann Allergy Asthma Immunol , vol.87 , pp. 311-318
    • Riediker, M.1    Monn, C.2    Koller, T.3
  • 7
    • 0019391781 scopus 로고    scopus 로고
    • Abelson MB, and Udell IJ. H2-receptors in the human ocular surface. Arch Ophthalmol 99:302-422, 1981.
    • Abelson MB, and Udell IJ. H2-receptors in the human ocular surface. Arch Ophthalmol 99:302-422, 1981.
  • 8
    • 0001374044 scopus 로고    scopus 로고
    • Current and future topical treatments for ocular allergy
    • Abelson MB, and Chapin MJ. Current and future topical treatments for ocular allergy. Comp Ophthalmol Update 1:303-317, 2000.
    • (2000) Comp Ophthalmol Update , vol.1 , pp. 303-317
    • Abelson, M.B.1    Chapin, M.J.2
  • 9
    • 0141613189 scopus 로고    scopus 로고
    • Efficacy and safety of ketotifen eye drops as adjunctive therapy to mometasone nasal spray in subjects with seasonal allergic rhinoconjunctivitis
    • Horak F, Stuebner P, Zieglmayer R, et al. Efficacy and safety of ketotifen eye drops as adjunctive therapy to mometasone nasal spray in subjects with seasonal allergic rhinoconjunctivitis. Clin Drug Investig 23:597-604, 2003.
    • (2003) Clin Drug Investig , vol.23 , pp. 597-604
    • Horak, F.1    Stuebner, P.2    Zieglmayer, R.3
  • 10
    • 3042582150 scopus 로고    scopus 로고
    • Treatment with intranasal fluticasone propionate significantly improves ocular symptoms in patients with seasonal allergic rhinitis
    • Bernstein DI, Levy AL, Hampel FC, et al. Treatment with intranasal fluticasone propionate significantly improves ocular symptoms in patients with seasonal allergic rhinitis. Clin Exp Allergy 34:952-957, 2004.
    • (2004) Clin Exp Allergy , vol.34 , pp. 952-957
    • Bernstein, D.I.1    Levy, A.L.2    Hampel, F.C.3
  • 11
    • 0242521710 scopus 로고    scopus 로고
    • The efficacy of intranasal fluticasone propionate in the relief of ocular symptoms associated with seasonal allergic rhinitis
    • DeWester J, Philpot EE, Westlund RE, et al. The efficacy of intranasal fluticasone propionate in the relief of ocular symptoms associated with seasonal allergic rhinitis. Allergy Asthma Proc 24:331-337, 2003.
    • (2003) Allergy Asthma Proc , vol.24 , pp. 331-337
    • DeWester, J.1    Philpot, E.E.2    Westlund, R.E.3
  • 13
    • 0025166468 scopus 로고
    • Conjunctival allergen challenge. A clinical approach to studying allergic conjunctivitis
    • Abelson MB, Chambers WA, and Smith LM. Conjunctival allergen challenge. A clinical approach to studying allergic conjunctivitis. Arch Ophthalmol 108:84 8, 1990.
    • (1990) Arch Ophthalmol , vol.108 , pp. 84-88
    • Abelson, M.B.1    Chambers, W.A.2    Smith, L.M.3
  • 14
    • 0034869181 scopus 로고    scopus 로고
    • Evaluation of the efficacy of olopatadine hydrochloride 0.01% ophthalmic solution and azelastine hydrochloride 0.05% ophthalmic solution in the conjunctival allergen challenge model
    • Spangler DL, Bensch G, and Berdy GJ. Evaluation of the efficacy of olopatadine hydrochloride 0.01% ophthalmic solution and azelastine hydrochloride 0.05% ophthalmic solution in the conjunctival allergen challenge model. Clin Ther 23:1272-1280, 2001.
    • (2001) Clin Ther , vol.23 , pp. 1272-1280
    • Spangler, D.L.1    Bensch, G.2    Berdy, G.J.3
  • 15
    • 61849142938 scopus 로고    scopus 로고
    • Efficacy and tolerability of ophthalmic epinastine using the conjunctival antigen challenge model in patients
    • Abelson MB, Gomes P, Crampton HJ, et al. Efficacy and tolerability of ophthalmic epinastine using the conjunctival antigen challenge model in patients. Clin Ther 26:35047, 2004.
    • (2004) Clin Ther , vol.26 , pp. 35047
    • Abelson, M.B.1    Gomes, P.2    Crampton, H.J.3
  • 16
    • 0344441354 scopus 로고    scopus 로고
    • Efficacy and safety of ketotifen fumarate 0.025% in the conjuncunctival antigen challenge model of ocular allergic conjunctivitis
    • Greiner JV, Mundorf T, Dubiner H, et al. Efficacy and safety of ketotifen fumarate 0.025% in the conjuncunctival antigen challenge model of ocular allergic conjunctivitis. Am J Ophthalmol 136:1097-1105, 2003.
    • (2003) Am J Ophthalmol , vol.136 , pp. 1097-1105
    • Greiner, J.V.1    Mundorf, T.2    Dubiner, H.3
  • 17
    • 0031661326 scopus 로고    scopus 로고
    • Evaluation of olopatadine, a new ophthalmic antiallergic agent with dual activity, using the conjunctival allergen challenge model
    • Abelson MD. Evaluation of olopatadine, a new ophthalmic antiallergic agent with dual activity, using the conjunctival allergen challenge model. Ann Allergy Asthma Immunol 82:211-218, 1998.
    • (1998) Ann Allergy Asthma Immunol , vol.82 , pp. 211-218
    • Abelson, M.D.1
  • 18
    • 61849160556 scopus 로고    scopus 로고
    • Available online at, accessed September 9, 2008
    • Veramyst Prescribing Information. Lines 574-577. Available online at www.fda.gov/cder/foi/label/2007/022051lbl.pdf; accessed September 9, 2008.
    • Veramyst Prescribing Information. Lines 574-577
  • 19
    • 39149123283 scopus 로고    scopus 로고
    • Ocular symptom reduction in patients with seasonal allergic rhinitis treated with the intranasal corticosteroid mometasone furoate
    • Bielory L. Ocular symptom reduction in patients with seasonal allergic rhinitis treated with the intranasal corticosteroid mometasone furoate. Ann Allergy Asthma Immunol 100:272-279, 2008.
    • (2008) Ann Allergy Asthma Immunol , vol.100 , pp. 272-279
    • Bielory, L.1
  • 20
    • 0041418008 scopus 로고    scopus 로고
    • Azelastine nasal spray: A review of pharmacology and clinical efficacy in allergic and nonallergic rhinitis
    • Lieberman PL, and Settipane RA. Azelastine nasal spray: A review of pharmacology and clinical efficacy in allergic and nonallergic rhinitis. Allergy Asthma Proc 24:95-105, 2003.
    • (2003) Allergy Asthma Proc , vol.24 , pp. 95-105
    • Lieberman, P.L.1    Settipane, R.A.2
  • 22
    • 0028357740 scopus 로고
    • Effect of nasal anaesthesia on lacrimal function after nasal allergen challenge
    • Löth S, and Bende M. Effect of nasal anaesthesia on lacrimal function after nasal allergen challenge. Clin Exp Allergy 24:375-376, 1994.
    • (1994) Clin Exp Allergy , vol.24 , pp. 375-376
    • Löth, S.1    Bende, M.2
  • 23
    • 34548379185 scopus 로고    scopus 로고
    • Absolute bioavailability of intranasal fluticasone furoate in healthy subjects
    • Allen A, Down G, Newland A, et al. Absolute bioavailability of intranasal fluticasone furoate in healthy subjects. Clin Ther 29:1415-1420, 2007.
    • (2007) Clin Ther , vol.29 , pp. 1415-1420
    • Allen, A.1    Down, G.2    Newland, A.3
  • 24
    • 0035702570 scopus 로고    scopus 로고
    • The effect of inferior turbinate hypertrophy on nasal spray distribution to the middle meatus
    • Dowley AC, and Homer JJ. The effect of inferior turbinate hypertrophy on nasal spray distribution to the middle meatus. Clin Otolaryngol 26:488-490, 2001.
    • (2001) Clin Otolaryngol , vol.26 , pp. 488-490
    • Dowley, A.C.1    Homer, J.J.2
  • 25
    • 33748546893 scopus 로고    scopus 로고
    • Anatomy of the orbit, lacrimal apparatus, and lateral nasal wall
    • Chastain JB, and Sindwani R. Anatomy of the orbit, lacrimal apparatus, and lateral nasal wall. Otolaryngol Clin North Am 39:855-864, 2006.
    • (2006) Otolaryngol Clin North Am , vol.39 , pp. 855-864
    • Chastain, J.B.1    Sindwani, R.2
  • 26
    • 25444435828 scopus 로고    scopus 로고
    • Effects of adjuvant therapy with 0.1% olopatadine hydrochloride ophthalmic solution on quality of life in patients with allergic rhinitis using systemic or nasal therapy
    • Berger W, Abelson MB, Gomes PJ, et al. Effects of adjuvant therapy with 0.1% olopatadine hydrochloride ophthalmic solution on quality of life in patients with allergic rhinitis using systemic or nasal therapy. Ann Allergy Asthma Immunol 95:361-371, 2005.
    • (2005) Ann Allergy Asthma Immunol , vol.95 , pp. 361-371
    • Berger, W.1    Abelson, M.B.2    Gomes, P.J.3
  • 27
    • 0036627699 scopus 로고    scopus 로고
    • A randomized comparison of the effects of budesonide and mometasone furoate aqueous nasal sprays on nasal peak flow rate and symptoms in perennial allergic rhinitis
    • Bende M, Carrillo T, Vóna I, et al. A randomized comparison of the effects of budesonide and mometasone furoate aqueous nasal sprays on nasal peak flow rate and symptoms in perennial allergic rhinitis. Ann Allergy Asthma Immunol 88:617-623, 2002.
    • (2002) Ann Allergy Asthma Immunol , vol.88 , pp. 617-623
    • Bende, M.1    Carrillo, T.2    Vóna, I.3
  • 28
    • 20444502234 scopus 로고    scopus 로고
    • Seasonal and perennial allergic rhinitis: Is this classification adherent to real life?
    • Ciprandi G, Cirillo I, Vizzaccaro A, et al. Seasonal and perennial allergic rhinitis: Is this classification adherent to real life? Allergy 60:882-887, 2005.
    • (2005) Allergy , vol.60 , pp. 882-887
    • Ciprandi, G.1    Cirillo, I.2    Vizzaccaro, A.3
  • 29
    • 0002885825 scopus 로고    scopus 로고
    • The Aria Workshop Group, World Health Organization. Allergic rhinitis and its impact on asthma
    • Bousquet J, van Cauwenberge P, and Khaltaev N. The Aria Workshop Group, World Health Organization. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 108(suppl 5):S147-S334, 2001.
    • (2001) J Allergy Clin Immunol , vol.108 , Issue.SUPPL. 5
    • Bousquet, J.1    van Cauwenberge, P.2    Khaltaev, N.3
  • 30
    • 10744229377 scopus 로고    scopus 로고
    • PRAGMA. Validation of the classification of ARIA (allergic rhinitis and its impact on asthma)
    • Demoly P, Allaert FA, Lecasble M, and Bousquet J, PRAGMA. Validation of the classification of ARIA (allergic rhinitis and its impact on asthma). Allergy 58:672-675, 2003.
    • (2003) Allergy , vol.58 , pp. 672-675
    • Demoly, P.1    Allaert, F.A.2    Lecasble, M.3    Bousquet, J.4
  • 31
    • 0041885423 scopus 로고    scopus 로고
    • Randomized, doubled-masked comparison of olopatadine ophthalmic solution, mometasone furoate monohydrate nasal spray, and fexofenadine hydrochloride tablets using the conjunctival and nasal allergen challenge models
    • Spangler DL, Abelson MB, Ober A, and Gomes PJ. Randomized, doubled-masked comparison of olopatadine ophthalmic solution, mometasone furoate monohydrate nasal spray, and fexofenadine hydrochloride tablets using the conjunctival and nasal allergen challenge models. Clin Ther 25:2245-2267, 2003.
    • (2003) Clin Ther , vol.25 , pp. 2245-2267
    • Spangler, D.L.1    Abelson, M.B.2    Ober, A.3    Gomes, P.J.4
  • 32
    • 34347330146 scopus 로고    scopus 로고
    • An open-label, investigator-masked, crossover study pf the ocular drying effects of two antihistamines, topical epinastine and systemic loratadine, in adult volunteers with seasonal allergic conjunctivitis
    • Ousler GW III, Workman DA, and Torkildsen GL. An open-label, investigator-masked, crossover study pf the ocular drying effects of two antihistamines, topical epinastine and systemic loratadine, in adult volunteers with seasonal allergic conjunctivitis. Clin Ther 29:611-616, 2007.
    • (2007) Clin Ther , vol.29 , pp. 611-616
    • Ousler III, G.W.1    Workman, D.A.2    Torkildsen, G.L.3
  • 33
    • 39749169725 scopus 로고    scopus 로고
    • Evaluation of the effects of olopatadine ophthalmic solution, 0.2% on the ocular surface of patients with allergic conjunctivitis and dry eye
    • Mah FS, O'Brien T, Kim T, and Torkildsen G. Evaluation of the effects of olopatadine ophthalmic solution, 0.2% on the ocular surface of patients with allergic conjunctivitis and dry eye. Curr Med Res Opin 24:441-447, 2008.
    • (2008) Curr Med Res Opin , vol.24 , pp. 441-447
    • Mah, F.S.1    O'Brien, T.2    Kim, T.3    Torkildsen, G.4
  • 34
    • 0036921852 scopus 로고    scopus 로고
    • Ocular drying associated with oral antihistamines (loratadine) in the normal population - An evaluation of exaggerated dose effect
    • Welch D, Ousler GW, Nally LA, et al. Ocular drying associated with oral antihistamines (loratadine) in the normal population - An evaluation of exaggerated dose effect. Adv Exp Med Biol 506:1051-1055, 2002.
    • (2002) Adv Exp Med Biol , vol.506 , pp. 1051-1055
    • Welch, D.1    Ousler, G.W.2    Nally, L.A.3
  • 35
    • 30844450124 scopus 로고    scopus 로고
    • Azelastine nasal spray and desloratadine tablets in pollen-induced seasonal allergic rhinitis: A pharmacodynamic study of onset of action and efficacy
    • Horak F, Zieglmayer UP, Zieglmayer R, et al. Azelastine nasal spray and desloratadine tablets in pollen-induced seasonal allergic rhinitis: A pharmacodynamic study of onset of action and efficacy. Curr Med Res Opin 22:151-157, 2006.
    • (2006) Curr Med Res Opin , vol.22 , pp. 151-157
    • Horak, F.1    Zieglmayer, U.P.2    Zieglmayer, R.3
  • 36
    • 0033626457 scopus 로고    scopus 로고
    • An evaluation of onset and duration of action of Patanol (Olopatadine hydrochloride ophthalmic solution 0.1%) compared to Claritin (Loratadine 10 mg) tablets in acute allergic conjunctivitis in the conjunctival allergen challenge model
    • Abelson MB, and Welch DL. An evaluation of onset and duration of action of Patanol (Olopatadine hydrochloride ophthalmic solution 0.1%) compared to Claritin (Loratadine 10 mg) tablets in acute allergic conjunctivitis in the conjunctival allergen challenge model. Acta Ophthalmol Scand 78:60-63, 2000.
    • (2000) Acta Ophthalmol Scand , vol.78 , pp. 60-63
    • Abelson, M.B.1    Welch, D.L.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.